FDA Biologics (BLA & Biosimilars)Original article
Workshops, Meetings & Conferences (Biologics)
ConferenceNeutral
AI Analysis
Summary
FDA's Center for Drug Evaluation and Research (CBER) sponsors or co-sponsors meetings, conferences and workshops to educate the public and gather stakeholder opinions on biologics development. This is a routine informational announcement about workshop availability.
Importance:2/10
Sentiment:
0.00
regulatoryconferenceeducationCBERbiologics
Read the original article
Published by FDA Biologics (BLA & Biosimilars) on September 16, 2026 5:56 PM